Why Moleculin Biotech Inc (MBRX) Stock Is Rising
As of 2026-08-12, Moleculin Biotech Inc (MBRX) has a next-year EPS growth estimate of 41.61%. Featured in our EPS revision report on 2026-08-12.
Why MBRX Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Moleculin Biotech Inc's next-year EPS growth estimate from 37.35% to 41.61% on 2026-08-04.
- ·Current-Year Growth: Projected at 83.23%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 41.61%
- EPS growth this year
- 83.23%
- EPS next quarter (est)
- -$1.55
- Last price
- $0.52
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-12 | 41.61% | 83.23% | -$1.55 | $0.52 |
| 2026-08-11 | 41.61% | 83.23% | -$1.55 | $0.44 |
| 2026-08-10 | 41.61% | 83.23% | -$1.55 | $0.43 |
| 2026-08-09 | 41.61% | 83.23% | -$1.55 | $0.41 |
| 2026-08-07 | 41.61% | 83.23% | -$1.55 | $0.41 |
| 2026-08-06 | 41.61% | 83.23% | -$1.55 | $0.38 |
| 2026-08-05 | 41.61% | 83.23% | -$1.55 | $0.39 |
| 2026-08-04 | 41.61% | 83.23% | -$1.55 | $0.41 |
| 2026-08-03 | 37.35% | 81.30% | -$1.60 | $0.43 |
| 2026-08-02 | 37.35% | 81.30% | -$1.60 | $0.40 |
| 2026-07-31 | 37.35% | 81.30% | -$1.60 | $0.40 |
| 2026-07-30 | 37.35% | 81.30% | -$1.60 | $1.02 |
| 2026-07-29 | 37.35% | 81.30% | -$1.60 | $1.36 |
| 2026-07-28 | 37.35% | 81.30% | -$1.60 | $2.19 |
| 2026-07-27 | 37.35% | 81.30% | -$1.60 | $2.19 |
| 2026-07-26 | 37.35% | 81.30% | -$1.60 | $2.12 |
| 2026-07-24 | 37.35% | 81.30% | -$1.60 | $2.12 |
| 2026-07-23 | 37.35% | 81.30% | -$1.60 | $2.08 |
| 2026-07-22 | 37.35% | 81.30% | -$1.60 | $2.10 |
| 2026-07-21 | 37.35% | 81.30% | -$1.60 | $2.15 |
| 2026-07-20 | 37.35% | 81.30% | -$1.60 | $2.14 |
| 2026-07-19 | 37.35% | 81.30% | -$1.60 | $2.10 |
| 2026-07-17 | 37.35% | 81.30% | -$1.60 | $2.10 |
| 2026-07-16 | 37.35% | 81.30% | -$1.60 | $2.17 |
| 2026-07-15 | 37.35% | 81.30% | -$1.60 | $2.31 |
| 2026-07-14 | 37.35% | 81.30% | -$1.60 | $2.26 |
| 2026-07-13 | 37.35% | 81.30% | -$1.60 | $2.21 |
| 2026-07-12 | 37.35% | 81.30% | -$1.60 | $2.28 |
| 2026-07-09 | 37.35% | 81.30% | -$1.60 | $2.44 |
| 2026-07-08 | 37.35% | 81.30% | -$1.60 | $2.37 |
Reports Featuring MBRX
Recent News
Screen Performance
Aggregate stats across all 1962 tickers our top-EPS-revision screen has flagged over the past 133 days.
- Median return since detection
- +4.0%
- % of tickers in the green
- 57%
- Median return on winners
- +22.0%
- Large revisions captured
- 1442
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Moleculin Biotech Inc (MBRX) stock go up recently?▾
Moleculin Biotech Inc (MBRX) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 37.35% to 41.61% on 2026-08-04. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Moleculin Biotech Inc's next-year EPS growth estimate?▾
As of 2026-08-12, Moleculin Biotech Inc (MBRX) has a next-year EPS growth estimate of 41.61%, based on analyst consensus.
When was the latest EPS estimate revision for MBRX?▾
The most recent revision occurred on 2026-08-04, when analysts adjusted the next-year EPS growth estimate from 37.35% to 41.61%.
What sector and industry does Moleculin Biotech Inc belong to?▾
Moleculin Biotech Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MBRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Moleculin Biotech Inc (MBRX) appears here because it was detected by our daily top-EPS-revision-performer screen.